gamma-Aminobutyric Acid-ergic Agonist [EPC]

gamma-Aminobutyric Acid-ergic Agonist [EPC] was reported 89408 times

These side effects are most commonly reported by patients taking drugs of the gamma-Aminobutyric Acid-ergic Agonist [EPC] class:

# Drug class Count
0 FATIGUE 6360
1 DRUG INEFFECTIVE 5932
2 PAIN 5904
3 FALL 5607
4 NAUSEA 4805
5 HEADACHE 4571
6 GAIT DISTURBANCE 4202
7 OFF LABEL USE 3926
8 DIZZINESS 3680
9 URINARY TRACT INFECTION 3618
10 ASTHENIA 3511
11 MUSCLE SPASMS 3502
12 MULTIPLE SCLEROSIS RELAPSE 3432
13 DIARRHOEA 3185
14 MUSCLE SPASTICITY 3015
15 VOMITING 2979
16 SOMNOLENCE 2842
17 INSOMNIA 2766
18 DYSPNOEA 2757
19 PAIN IN EXTREMITY 2708
20 BACK PAIN 2536
21 MALAISE 2526
22 DEPRESSION 2490
23 CONDITION AGGRAVATED 2444
24 MUSCULAR WEAKNESS 2410
25 HYPOAESTHESIA 2400
26 PNEUMONIA 2388
27 ARTHRALGIA 2376
28 MULTIPLE SCLEROSIS 2350
29 PYREXIA 2297
30 ANXIETY 2207
31 TOXICITY TO VARIOUS AGENTS 2168
32 BALANCE DISORDER 2096
33 DEATH 2056
34 PRURITUS 2028
35 MEMORY IMPAIRMENT 2023
36 DRUG WITHDRAWAL SYNDROME 1977
37 TREMOR 1962
38 OVERDOSE 1936
39 FEELING ABNORMAL 1895
40 WEIGHT DECREASED 1844
41 CONSTIPATION 1839
42 CONFUSIONAL STATE 1802
43 PARAESTHESIA 1776
44 RASH 1714
45 SEIZURE 1673
46 HYPERTENSION 1626
47 MUSCULOSKELETAL STIFFNESS 1603
48 FLUSHING 1588
49 COVID-19 1514
50 COMPLETED SUICIDE 1459
51 COMA 1435
52 PRODUCT DOSE OMISSION ISSUE 1431
53 COUGH 1405
54 HYPOTENSION 1373
55 MOBILITY DECREASED 1333
56 WEIGHT INCREASED 1275
57 LOSS OF CONSCIOUSNESS 1253
58 DRUG HYPERSENSITIVITY 1252
59 ABDOMINAL PAIN UPPER 1218
60 ALOPECIA 1218
61 HYPERHIDROSIS 1218
62 NASOPHARYNGITIS 1203
63 INFECTION 1159
64 MIGRAINE 1120
65 ENCEPHALOPATHY 1106
66 DECREASED APPETITE 1095
67 CHEST PAIN 1092
68 WITHDRAWAL SYNDROME 1092
69 DRUG INTERACTION 1087
70 INFLUENZA LIKE ILLNESS 1077
71 DRUG DOSE OMISSION 1063
72 PERIPHERAL SWELLING 1038
73 PRODUCT USE IN UNAPPROVED INDICATION 1030
74 ABDOMINAL PAIN 1026
75 ACUTE KIDNEY INJURY 1017
76 MYALGIA 1005
77 VISION BLURRED 1004
78 ABDOMINAL DISCOMFORT 998
79 BLOOD PRESSURE INCREASED 986
80 SEPSIS 958
81 DYSPHAGIA 951
82 GASTROOESOPHAGEAL REFLUX DISEASE 931
83 THERAPY CESSATION 925
84 HYPERSENSITIVITY 923
85 CHRONIC KIDNEY DISEASE 909
86 CHILLS 905
87 VISUAL IMPAIRMENT 888
88 CONTUSION 883
89 MENTAL STATUS CHANGES 869
90 DELIRIUM 850
91 DEHYDRATION 834
92 INFLUENZA 821
93 INJECTION SITE PAIN 819
94 HALLUCINATION 804
95 AGITATION 797
96 SINUSITIS 791
97 WHITE BLOOD CELL COUNT DECREASED 791
98 BURNING SENSATION 782
99 ERYTHEMA 782
100 RENAL FAILURE 776
101 OEDEMA PERIPHERAL 769
102 DEVICE ISSUE 760
103 HEART RATE INCREASED 745
104 TACHYCARDIA 732
105 LETHARGY 722
106 STRESS 722
107 INTENTIONAL OVERDOSE 717
108 URINARY INCONTINENCE 708
109 CONVULSION 704
110 NECK PAIN 695
111 URTICARIA 691
112 CEREBROVASCULAR ACCIDENT 690
113 PNEUMONIA ASPIRATION 690
114 AMNESIA 683
115 BRONCHITIS 673
116 COGNITIVE DISORDER 673
117 JOINT SWELLING 670
118 RHEUMATOID ARTHRITIS 661
119 UNRESPONSIVE TO STIMULI 660
120 BRADYCARDIA 658
121 RESPIRATORY FAILURE 655
122 PALPITATIONS 654
123 ANAEMIA 651
124 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 644
125 NEUROPATHY PERIPHERAL 642
126 SPEECH DISORDER 641
127 DYSPEPSIA 630
128 DEPRESSED LEVEL OF CONSCIOUSNESS 626
129 OROPHARYNGEAL PAIN 626
130 PRODUCT USE ISSUE 620
131 NEURALGIA 616
132 SLEEP DISORDER 609
133 FEELING HOT 604
134 DRY MOUTH 597
135 ILLNESS 590
136 NEPHROLITHIASIS 590
137 UNEVALUABLE EVENT 582
138 CHEST DISCOMFORT 577
139 SUICIDAL IDEATION 570
140 ARTHRITIS 569
141 HOSPITALISATION 568
142 MYOCARDIAL INFARCTION 568
143 PRODUCT DOSE OMISSION 556
144 INCORRECT DOSE ADMINISTERED 555
145 DYSARTHRIA 554
146 CARDIAC ARREST 553
147 DYSKINESIA 553
148 CYSTITIS 549
149 SYNCOPE 548
150 URINARY RETENTION 548
151 MUSCLE TIGHTNESS 546
152 DRUG INTOLERANCE 545
153 INJECTION SITE ERYTHEMA 542
154 DEVICE MALFUNCTION 541
155 GENERAL PHYSICAL HEALTH DETERIORATION 541
156 SWELLING 539
157 PULMONARY EMBOLISM 536
158 DYSSTASIA 533
159 ABDOMINAL DISTENSION 530
160 HOT FLUSH 530
161 DEVICE FAILURE 527
162 DISTURBANCE IN ATTENTION 525
163 THERAPEUTIC RESPONSE DECREASED 524
164 THERAPEUTIC RESPONSE UNEXPECTED 523
165 MOVEMENT DISORDER 522
166 GASTROINTESTINAL DISORDER 513
167 CELLULITIS 510
168 ASTHMA 506
169 ABASIA 505
170 IMPLANT SITE INFECTION 502
171 POLLAKIURIA 502
172 SUICIDE ATTEMPT 500
173 UNDERDOSE 499
174 RESPIRATORY DEPRESSION 498
175 SEDATION 494
176 DRUG DEPENDENCE 490
177 HYPOTONIA 488
178 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 485
179 BLOOD GLUCOSE INCREASED 481
180 HERPES ZOSTER 481
181 ADVERSE DRUG REACTION 473
182 CENTRAL NERVOUS SYSTEM LESION 473
183 INTENTIONAL PRODUCT USE ISSUE 469
184 DISORIENTATION 467
185 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 467
186 VERTIGO 467
187 NO THERAPEUTIC RESPONSE 466
188 INTENTIONAL PRODUCT MISUSE 465
189 LIMB DISCOMFORT 465
190 HEPATIC ENZYME INCREASED 452
191 DRUG ABUSE 449
192 BLOOD PRESSURE DECREASED 448
193 DEPRESSED MOOD 448
194 IRRITABILITY 444
195 GAIT INABILITY 443
196 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 443
197 MUSCULOSKELETAL PAIN 438
198 THERAPY NON-RESPONDER 438
199 ROAD TRAFFIC ACCIDENT 437
200 OSTEOARTHRITIS 425
201 LYMPHOCYTE COUNT DECREASED 422
202 THROMBOSIS 421
203 SLEEP APNOEA SYNDROME 420
204 HAEMOGLOBIN DECREASED 419
205 STAPHYLOCOCCAL INFECTION 418
206 DEVICE DISLOCATION 412
207 HYPERTONIA 404
208 HEAD INJURY 399
209 DEEP VEIN THROMBOSIS 396
210 OXYGEN SATURATION DECREASED 393
211 INTERVERTEBRAL DISC PROTRUSION 390
212 UPPER RESPIRATORY TRACT INFECTION 389
213 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 388
214 EMOTIONAL DISTRESS 384
215 RHINORRHOEA 384
216 SURGERY 381
217 DISEASE PROGRESSION 380
218 DYSURIA 379
219 DIPLOPIA 377
220 DECUBITUS ULCER 376
221 DIABETES MELLITUS 375
222 MUSCLE TWITCHING 371
223 NO ADVERSE EVENT 367
224 INFUSION RELATED REACTION 365
225 INJECTION SITE REACTION 364
226 CARDIAC DISORDER 357
227 DRUG EFFECT DECREASED 357
228 HYPERSOMNIA 357
229 OSTEOPOROSIS 357
230 APHASIA 351
231 ATRIAL FIBRILLATION 351
232 NASAL CONGESTION 350
233 DISCOMFORT 348
234 TINNITUS 347
235 TREATMENT FAILURE 346
236 PSORIASIS 345
237 HEART RATE DECREASED 342
238 NEUROTOXICITY 342
239 IMPLANT SITE EXTRAVASATION 340
240 DRY SKIN 339
241 EYE PAIN 338
242 RESPIRATORY ARREST 334
243 MICTURITION URGENCY 330
244 ARTHROPATHY 327
245 ATAXIA 324
246 FIBROMYALGIA 324
247 HYPOKINESIA 322
248 OEDEMA 322
249 DYSPHONIA 321
250 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 317
251 DYSTONIA 315
252 PRODUCT QUALITY ISSUE 314
253 INJECTION SITE BRUISING 313
254 CARDIO-RESPIRATORY ARREST 311
255 PLATELET COUNT DECREASED 310
256 PERONEAL NERVE PALSY 308
257 ADVERSE EVENT 306
258 HYPONATRAEMIA 305
259 THROAT IRRITATION 305
260 ALANINE AMINOTRANSFERASE INCREASED 304
261 BLOOD POTASSIUM DECREASED 304
262 HIP FRACTURE 304
263 MYOCLONUS 302
264 THERAPY INTERRUPTED 301
265 COMPLICATION ASSOCIATED WITH DEVICE 300
266 INFLAMMATION 299
267 STOMATITIS 299
268 SWELLING FACE 297
269 BLADDER DISORDER 294
270 MENTAL DISORDER 294
271 FLUID RETENTION 293
272 NEUTROPENIA 291
273 CEREBROSPINAL FLUID LEAKAGE 289
274 SENSORY DISTURBANCE 288
275 WHEEZING 288
276 ABNORMAL BEHAVIOUR 287
277 HEMIPARESIS 285
278 ILL-DEFINED DISORDER 283
279 WHITE BLOOD CELL COUNT INCREASED 283
280 AGGRESSION 282
281 BLOOD CHOLESTEROL INCREASED 282
282 TREATMENT NONCOMPLIANCE 282
283 BONE PAIN 279
284 DYSGEUSIA 279
285 HYPOKALAEMIA 279
286 FLATULENCE 278
287 ALTERED STATE OF CONSCIOUSNESS 276
288 CATARACT 275
289 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 275
290 DRY EYE 273
291 INJURY 272
292 NERVOUSNESS 272
293 CRYING 271
294 MUSCLE RIGIDITY 271
295 ACCIDENTAL OVERDOSE 270
296 PANIC ATTACK 270
297 RENAL IMPAIRMENT 270
298 LIMB INJURY 269
299 MUSCULOSKELETAL DISORDER 268
300 COORDINATION ABNORMAL 263
301 HAEMORRHAGE 263
302 BODY TEMPERATURE INCREASED 262
303 BLISTER 260
304 THROMBOCYTOPENIA 255
305 VIRAL INFECTION 255
306 EAR INFECTION 253
307 POOR QUALITY SLEEP 253
308 RIB FRACTURE 252
309 GASTRIC DISORDER 251
310 ASPARTATE AMINOTRANSFERASE INCREASED 250
311 PSYCHOTIC DISORDER 250
312 STATUS EPILEPTICUS 250
313 FOOT FRACTURE 248
314 NIGHTMARE 246
315 UROSEPSIS 246
316 RESTLESSNESS 245
317 RHABDOMYOLYSIS 244
318 DEVICE INFUSION ISSUE 243
319 FEELING COLD 243
320 TEMPERATURE INTOLERANCE 243
321 RESTLESS LEGS SYNDROME 242
322 WHITE BLOOD CELL COUNT ABNORMAL 242
323 LOWER LIMB FRACTURE 241
324 DEVICE OCCLUSION 240
325 PARALYSIS 240
326 RESPIRATORY DISTRESS 240
327 ANKLE FRACTURE 239
328 CARDIAC FAILURE CONGESTIVE 239
329 IMPAIRED HEALING 239
330 HYPOXIA 235
331 PRODUCTIVE COUGH 235
332 BREAST CANCER 232
333 EPILEPSY 232
334 GENERALISED TONIC-CLONIC SEIZURE 232
335 CHOLELITHIASIS 230
336 EPISTAXIS 230
337 LABORATORY TEST ABNORMAL 229
338 SKIN EXFOLIATION 229
339 GASTROINTESTINAL HAEMORRHAGE 228
340 MEDICATION ERROR 228
341 FUNGAL INFECTION 225
342 HYPOTHYROIDISM 225
343 SEPTIC SHOCK 225
344 THERAPEUTIC PRODUCT EFFECT DECREASED 225
345 MOTOR DYSFUNCTION 224
346 SKIN DISCOLOURATION 224
347 HALLUCINATION, VISUAL 223
348 RESPIRATORY DISORDER 223
349 ANAPHYLACTIC REACTION 222
350 TOXIC ENCEPHALOPATHY 222
351 TRANSIENT ISCHAEMIC ATTACK 222
352 SEROTONIN SYNDROME 221
353 ACTIVITIES OF DAILY LIVING IMPAIRED 219
354 INTESTINAL OBSTRUCTION 219
355 BACK DISORDER 218
356 LOWER RESPIRATORY TRACT INFECTION 218
357 MENTAL IMPAIRMENT 218
358 RENAL INJURY 218
359 CONTRAINDICATED PRODUCT ADMINISTERED 215
360 KIDNEY INFECTION 215
361 WALKING AID USER 215
362 WOUND 215
363 JOINT INJURY 214
364 ELECTROCARDIOGRAM QT PROLONGED 213
365 END STAGE RENAL DISEASE 213
366 INCONTINENCE 213
367 NERVOUS SYSTEM DISORDER 213
368 NIGHT SWEATS 212
369 BLINDNESS 210
370 BLOOD CREATININE INCREASED 210
371 PRESCRIBED UNDERDOSE 210
372 INJECTION SITE MASS 209
373 TRIGEMINAL NEURALGIA 209
374 BLOOD PRESSURE SYSTOLIC INCREASED 208
375 DEVICE LEAKAGE 208
376 HEPATIC STEATOSIS 207
377 CLONUS 205
378 PANCREATITIS 205
379 ACUTE RESPIRATORY FAILURE 204
380 RASH PRURITIC 204
381 INJECTION SITE SWELLING 203
382 VITAMIN D DEFICIENCY 203
383 LEUKOPENIA 202
384 LUNG DISORDER 202
385 BURSITIS 201
386 OBESITY 201
387 SCIATICA 201
388 ANAL INCONTINENCE 200
389 DEVICE BREAKAGE 199
390 DIVERTICULITIS 199
391 LOCALISED INFECTION 199
392 LYMPHOPENIA 199
393 ROTATOR CUFF SYNDROME 199
394 BEDRIDDEN 197
395 RED BLOOD CELL COUNT DECREASED 196
396 INTERVERTEBRAL DISC DEGENERATION 195
397 ORAL HERPES 195
398 SCOLIOSIS 195
399 MATERNAL EXPOSURE DURING PREGNANCY 194
400 FEMUR FRACTURE 192
401 IMPLANT SITE PAIN 192
402 INJECTION SITE PRURITUS 192
403 JOINT STIFFNESS 192
404 CARDIAC FAILURE 189
405 PRODUCT SUBSTITUTION ISSUE 189
406 HAEMATOCRIT DECREASED 188
407 HYPOACUSIS 188
408 HYPOTHERMIA 185
409 THERAPEUTIC RESPONSE SHORTENED 185
410 POST PROCEDURAL COMPLICATION 184
411 MIDDLE INSOMNIA 183
412 ABNORMAL DREAMS 182
413 ACNE 182
414 LIVER FUNCTION TEST ABNORMAL 182
415 OSTEOMYELITIS 182
416 IMPAIRED GASTRIC EMPTYING 181
417 SINUS DISORDER 181
418 MUSCULOSKELETAL DISCOMFORT 180
419 OPTIC NEURITIS 180
420 PRODUCT DOSE OMISSION IN ERROR 180
421 SEASONAL ALLERGY 180
422 LYMPHADENOPATHY 179
423 TYPE 2 DIABETES MELLITUS 179
424 C-REACTIVE PROTEIN INCREASED 178
425 ERECTILE DYSFUNCTION 178
426 PRODUCT PRESCRIBING ERROR 178
427 MOOD SWINGS 177
428 NOCTURIA 177
429 BLOOD PRESSURE FLUCTUATION 176
430 PARANOIA 175
431 ANGER 174
432 COLITIS 174
433 GASTRITIS 174
434 RENAL DISORDER 174
435 HAEMATOCHEZIA 172
436 HYPOPHAGIA 172
437 INJECTION SITE HAEMORRHAGE 172
438 NEUROGENIC BLADDER 172
439 POISONING DELIBERATE 172
440 RASH ERYTHEMATOUS 172
441 CONCUSSION 171
442 SPINAL PAIN 171
443 DEVICE KINK 170
444 SPINAL OPERATION 170
445 MUSCLE ATROPHY 169
446 RESPIRATORY TRACT INFECTION 169
447 PULMONARY OEDEMA 168
448 SENSORY LOSS 168
449 EXTRA DOSE ADMINISTERED 167
450 EYE DISORDER 167
451 SCAR 166
452 SKIN ULCER 166
453 IRRITABLE BOWEL SYNDROME 165
454 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 165
455 SPINAL OSTEOARTHRITIS 165
456 CHROMATURIA 164
457 DEVICE RELATED INFECTION 164
458 PAIN IN JAW 164
459 PLEURAL EFFUSION 164
460 SKIN DISORDER 163
461 DECREASED INTEREST 162
462 RENAL FAILURE ACUTE 162
463 PERIPHERAL COLDNESS 161
464 CANDIDA INFECTION 160
465 CLOSTRIDIUM DIFFICILE INFECTION 160
466 HYPERTONIC BLADDER 160
467 ANHEDONIA 159
468 BLOOD CREATINE PHOSPHOKINASE INCREASED 159
469 GASTROENTERITIS VIRAL 158
470 HAEMATOMA 157
471 NEOPLASM MALIGNANT 157
472 RECTAL HAEMORRHAGE 157
473 WHEELCHAIR USER 157
474 TENDERNESS 156
475 THYROID DISORDER 156
476 WOUND DEHISCENCE 156
477 SPINAL FRACTURE 155
478 UPPER LIMB FRACTURE 155
479 BRAIN FOG 154
480 CARPAL TUNNEL SYNDROME 154
481 ELECTROENCEPHALOGRAM ABNORMAL 154
482 EMOTIONAL DISORDER 154
483 NERVE COMPRESSION 152
484 SWOLLEN TONGUE 152
485 HAEMATEMESIS 151
486 LIP SWELLING 151
487 DRUG EFFECT INCOMPLETE 150
488 EUPHORIC MOOD 150
489 FEEDING DISORDER 150
490 PSORIATIC ARTHROPATHY 149
491 RETCHING 149
492 DEVICE DAMAGE 148
493 HYPERGLYCAEMIA 148
494 SINUS BRADYCARDIA 148
495 TOOTH DISORDER 148
496 BLOOD SODIUM DECREASED 147
497 EAR PAIN 147
498 BLOOD URINE PRESENT 146
499 EYE IRRITATION 146
500 LEUKOCYTOSIS 146
501 ACCIDENTAL EXPOSURE TO PRODUCT 145
502 ORAL PAIN 145
503 CHOKING 143
504 IMPLANT SITE SWELLING 143
505 NERVE INJURY 143
506 SKIN LACERATION 143
507 THINKING ABNORMAL 143
508 THROAT TIGHTNESS 143
509 GRAND MAL CONVULSION 142
510 HYPOGLYCAEMIA 142
511 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 142
512 MANIA 142
513 BLOOD GLUCOSE DECREASED 141
514 DYSPNOEA EXERTIONAL 141
515 PHOTOPHOBIA 141
516 ECZEMA 140
517 FEAR 139
518 HAEMATURIA 139
519 SKIN LESION 139
520 GLAUCOMA 138
521 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 138
522 RELAPSING-REMITTING MULTIPLE SCLEROSIS 138
523 INTENTIONAL DOSE OMISSION 137
524 LIVER DISORDER 137
525 TENDONITIS 137
526 ARRHYTHMIA 136
527 SKIN BURNING SENSATION 136
528 METABOLIC ENCEPHALOPATHY 135
529 OSTEOPENIA 135
530 ATELECTASIS 134
531 DEVICE ALARM ISSUE 134
532 ASPIRATION 133
533 BACTERIAL INFECTION 133
534 BLOOD PRESSURE ABNORMAL 133
535 DYSGRAPHIA 133
536 PARKINSON^S DISEASE 133
537 WOUND INFECTION 133
538 WRONG TECHNIQUE IN DRUG USAGE PROCESS 133
539 GAIT SPASTIC 132
540 PRE-EXISTING CONDITION IMPROVED 132
541 BLOOD ALKALINE PHOSPHATASE INCREASED 131
542 BRAIN INJURY 131
543 COLD SWEAT 131
544 DELUSION 131
545 ECONOMIC PROBLEM 131
546 HEART RATE IRREGULAR 131
547 INCOHERENT 131
548 NEUROLEPTIC MALIGNANT SYNDROME 131
549 SKIN REACTION 131
550 SPINAL DISORDER 131
551 HYPERAESTHESIA 130
552 INCORRECT ROUTE OF DRUG ADMINISTRATION 130
553 DISABILITY 129
554 ESCHERICHIA URINARY TRACT INFECTION 129
555 HAEMORRHOIDS 129
556 PROCEDURAL PAIN 129
557 SNEEZING 129
558 SYSTEMIC LUPUS ERYTHEMATOSUS 128
559 IMPLANT SITE EROSION 126
560 KNEE ARTHROPLASTY 126
561 COVID-19 PNEUMONIA 125
562 IMMUNODEFICIENCY 125
563 APNOEA 124
564 AREFLEXIA 124
565 NEPHROGENIC ANAEMIA 124
566 TARDIVE DYSKINESIA 124
567 HEAD DISCOMFORT 123
568 TOOTHACHE 123
569 CROHN^S DISEASE 122
570 MOOD ALTERED 122
571 MUSCULOSKELETAL CHEST PAIN 122
572 OCULAR HYPERAEMIA 122
573 PULMONARY CONGESTION 122
574 VISUAL ACUITY REDUCED 122
575 ACUTE MYOCARDIAL INFARCTION 121
576 DISEASE RECURRENCE 120
577 EATING DISORDER 120
578 MASS 120
579 IMPAIRED WORK ABILITY 119
580 LIGAMENT SPRAIN 119
581 MIOSIS 119
582 RASH MACULAR 119
583 EYE SWELLING 118
584 FACIAL PAIN 118
585 HYPOAESTHESIA ORAL 118
586 LACRIMATION INCREASED 118
587 MENINGITIS 118
588 PRODUCT ADHESION ISSUE 118
589 IMPAIRED DRIVING ABILITY 117
590 NEUTROPHIL COUNT DECREASED 117
591 PRODUCT ADMINISTRATION INTERRUPTED 117
592 NYSTAGMUS 116
593 PSYCHOMOTOR HYPERACTIVITY 116
594 DEMENTIA 114
595 INITIAL INSOMNIA 114
596 INTERVERTEBRAL DISC DISORDER 114
597 METABOLIC ACIDOSIS 114
598 PERFORMANCE STATUS DECREASED 114
599 DRUG LEVEL INCREASED 113
600 MAJOR DEPRESSION 112
601 MONOPARESIS 112
602 PROGRESSIVE MULTIPLE SCLEROSIS 112
603 WRIST FRACTURE 112
604 ASPHYXIA 111
605 HALLUCINATION, AUDITORY 111
606 HIP ARTHROPLASTY 111
607 JOINT DISLOCATION 111
608 PRESCRIBED OVERDOSE 111
609 URINE ANALYSIS ABNORMAL 111
610 VITAMIN D DECREASED 111
611 DRUG ADMINISTRATION ERROR 110
612 DRUG-INDUCED LIVER INJURY 110
613 POISONING 110
614 TUBULOINTERSTITIAL NEPHRITIS 110
615 FEELING JITTERY 109
616 PANCYTOPENIA 109
617 SUSPECTED SUICIDE 109
618 CLOSTRIDIUM DIFFICILE COLITIS 108
619 HEMIPLEGIA 107
620 LIVER FUNCTION TEST INCREASED 107
621 CEREBRAL DISORDER 106
622 POST-TRAUMATIC STRESS DISORDER 106
623 RESPIRATORY TRACT CONGESTION 106
624 SARS-COV-2 TEST POSITIVE 106
625 SKIN ABRASION 106
626 CORONARY ARTERY DISEASE 105
627 LOSS OF CONTROL OF LEGS 105
628 MYDRIASIS 105
629 TOOTH INFECTION 105
630 BRADYPNOEA 104
631 GAMMA-GLUTAMYLTRANSFERASE INCREASED 104
632 HYPERLIPIDAEMIA 104
633 PLASMA CELL MYELOMA 104
634 ABORTION SPONTANEOUS 103
635 FOETAL EXPOSURE DURING PREGNANCY 103
636 OSTEONECROSIS 103
637 RENAL CYST 103
638 CEREBRAL HAEMORRHAGE 102
639 HICCUPS 102
640 NEEDLE FATIGUE 102
641 AUTONOMIC NERVOUS SYSTEM IMBALANCE 101
642 FAECAL INCONTINENCE 101
643 HIATUS HERNIA 101
644 MALIGNANT NEOPLASM PROGRESSION 101
645 BASAL CELL CARCINOMA 100
646 BLOOD UREA INCREASED 100
647 DEAFNESS 100
648 GASTRIC ULCER 100
649 HYPERTHERMIA 100
650 BACK INJURY 99
651 BONE DISORDER 99
652 DRUG TOXICITY 99
653 JOINT RANGE OF MOTION DECREASED 99
654 ORTHOSTATIC HYPOTENSION 99
655 PALLOR 99
656 POST PROCEDURAL INFECTION 98
657 PRESYNCOPE 98
658 TASTE DISORDER 98
659 IMMUNE SYSTEM DISORDER 97
660 INFUSION SITE PAIN 97
661 BIPOLAR DISORDER 96
662 DYSAESTHESIA 96
663 GALLBLADDER DISORDER 96
664 HEPATIC FAILURE 96
665 HERNIA 96
666 ARTERIOSCLEROSIS CORONARY ARTERY 95
667 COMA SCALE ABNORMAL 95
668 DEVICE CONNECTION ISSUE 95
669 PHARYNGEAL SWELLING 95
670 CORONARY ARTERY OCCLUSION 94
671 GRIP STRENGTH DECREASED 94
672 INCREASED TENDENCY TO BRUISE 94
673 ANGIOEDEMA 93
674 CARDIOMEGALY 93
675 FEELING OF BODY TEMPERATURE CHANGE 93
676 MEDICAL DEVICE SITE INFECTION 93
677 MONOPLEGIA 93
678 NEUTROPHIL COUNT INCREASED 93
679 SKIN INFECTION 93
680 ANKYLOSING SPONDYLITIS 92
681 APATHY 92
682 BLINDNESS UNILATERAL 92
683 CIRCULATORY COLLAPSE 92
684 INTERNATIONAL NORMALISED RATIO INCREASED 92
685 SUPRAVENTRICULAR TACHYCARDIA 92
686 APHONIA 91
687 BODY HEIGHT DECREASED 91
688 CYST 90
689 EYE MOVEMENT DISORDER 90
690 HYPERKALAEMIA 90
691 MUSCLE DISORDER 90
692 SHOCK 90
693 TACHYPNOEA 90
694 TOOTH LOSS 90
695 BLOOD BILIRUBIN INCREASED 89
696 DENTAL CARIES 89
697 FEELING DRUNK 89
698 FRACTURE 89
699 INJECTION SITE URTICARIA 89
700 POSTOPERATIVE WOUND INFECTION 89
701 SYNOVITIS 89
702 ULCER 89
703 BONE DENSITY DECREASED 88
704 IMMUNOSUPPRESSION 88
705 DRUG EFFECT LESS THAN EXPECTED 87
706 FULL BLOOD COUNT DECREASED 87
707 LACTIC ACIDOSIS 87
708 SINUS TACHYCARDIA 87
709 ACCIDENT 86
710 HALLUCINATIONS, MIXED 86
711 SUBDURAL HAEMATOMA 86
712 ABSCESS 85
713 BLOOD TRIGLYCERIDES INCREASED 85
714 FEBRILE NEUTROPENIA 85
715 MUSCLE STRAIN 85
716 RESPIRATORY ACIDOSIS 85
717 SINUS CONGESTION 85
718 URINARY TRACT DISORDER 85
719 BLOOD MAGNESIUM DECREASED 84
720 HEPATIC CIRRHOSIS 84
721 INADEQUATE ANALGESIA 84
722 LOCAL SWELLING 84
723 RADICULOPATHY 84
724 DEMYELINATION 83
725 INSURANCE ISSUE 83
726 JC POLYOMAVIRUS TEST POSITIVE 83
727 MEDICAL DEVICE COMPLICATION 83
728 PSEUDOMONAS INFECTION 83
729 RED BLOOD CELL SEDIMENTATION RATE INCREASED 83
730 AGEUSIA 82
731 HAEMOGLOBIN INCREASED 82
732 KLEBSIELLA INFECTION 82
733 LYMPHOEDEMA 82
734 MULTIPLE ORGAN DYSFUNCTION SYNDROME 82
735 PERICARDIAL EFFUSION 82
736 PRODUCT ADMINISTRATION ERROR 82
737 TOOTH FRACTURE 82
738 ANGINA PECTORIS 81
739 BAND SENSATION 81
740 EXPOSURE DURING PREGNANCY 81
741 HAEMODYNAMIC INSTABILITY 81
742 MEDICAL DEVICE DISCOMFORT 81
743 PRURITUS GENERALISED 81
744 SMALL INTESTINAL OBSTRUCTION 81
745 SPINAL COLUMN STENOSIS 81
746 AFFECTIVE DISORDER 80
747 ANAPHYLACTIC SHOCK 80
748 BACTERAEMIA 80
749 BLOOD CALCIUM DECREASED 80
750 BRAIN OEDEMA 80
751 FOOT DEFORMITY 80
752 FREQUENT BOWEL MOVEMENTS 80
753 GASTROINTESTINAL INFECTION 80
754 HAND FRACTURE 80
755 IMPAIRED QUALITY OF LIFE 80
756 SALIVARY HYPERSECRETION 80
757 SEDATION COMPLICATION 80
758 URINE ODOUR ABNORMAL 80
759 DEVICE BATTERY ISSUE 79
760 HYPERREFLEXIA 79
761 PROSTATE CANCER 79
762 PULMONARY MASS 79
763 SKIN IRRITATION 79
764 DRUG PRESCRIBING ERROR 78
765 HAEMOPTYSIS 78
766 INJECTION SITE RASH 78
767 LACERATION 78
768 SCRATCH 78
769 SKIN CANCER 78
770 DECREASED IMMUNE RESPONSIVENESS 77
771 GASTROINTESTINAL MOTILITY DISORDER 77
772 ORAL CANDIDIASIS 77
773 POOR VENOUS ACCESS 77
774 PRODUCT AVAILABILITY ISSUE 77
775 REBOUND ACID HYPERSECRETION 77
776 SLUGGISHNESS 77
777 SPINAL COMPRESSION FRACTURE 77
778 UHTHOFF^S PHENOMENON 77
779 BLOOD TEST ABNORMAL 76
780 BRUXISM 76
781 CARDIOMYOPATHY 76
782 CARDIOVASCULAR DISORDER 76
783 CHOLECYSTITIS 76
784 EXOSTOSIS 76
785 RESPIRATORY RATE INCREASED 76
786 VAGINAL HAEMORRHAGE 76
787 ABDOMINAL PAIN LOWER 75
788 CHOLECYSTECTOMY 75
789 COLITIS MICROSCOPIC 75
790 DERMATITIS 75
791 EYE PRURITUS 75
792 FLANK PAIN 75
793 FORMICATION 75
794 GROIN PAIN 75
795 INJECTION SITE HAEMATOMA 75
796 MALIGNANT MELANOMA 75
797 SEROMA 75
798 SPINAL FUSION SURGERY 75
799 THIRST 75
800 CYANOSIS 74
801 ESCHERICHIA INFECTION 74
802 MALNUTRITION 74
803 MULTIPLE FRACTURES 74
804 MUSCLE CONTRACTIONS INVOLUNTARY 74
805 PARAPARESIS 74
806 PHARYNGEAL OEDEMA 74
807 PROCEDURAL COMPLICATION 74
808 RENAL PAIN 74
809 SOMNAMBULISM 74
810 WEIGHT FLUCTUATION 74
811 AFFECT LABILITY 73
812 BLOOD GLUCOSE ABNORMAL 73
813 BODY TEMPERATURE DECREASED 73
814 EAR DISCOMFORT 73
815 MITRAL VALVE INCOMPETENCE 73
816 MULTIPLE ALLERGIES 73
817 B-LYMPHOCYTE COUNT DECREASED 72
818 HYPERPARATHYROIDISM SECONDARY 72
819 MUSCLE CONTRACTURE 72
820 PARTIAL SEIZURES 72
821 QUALITY OF LIFE DECREASED 72
822 SNORING 72
823 BLOOD POTASSIUM INCREASED 71
824 DRUG DOSE OMISSION BY DEVICE 71
825 DRY THROAT 71
826 ELECTROLYTE IMBALANCE 71
827 EXTRAPYRAMIDAL DISORDER 71
828 GENERAL SYMPTOM 71
829 HYPERVENTILATION 71
830 PAIN OF SKIN 71
831 RED CELL DISTRIBUTION WIDTH INCREASED 71
832 BREAST CANCER FEMALE 70
833 DERMATITIS CONTACT 70
834 ERUCTATION 70
835 EXPIRED PRODUCT ADMINISTERED 70
836 ILEUS 70
837 INCORRECT DOSE ADMINISTERED BY DEVICE 70
838 INFUSION SITE MASS 70
839 NEUROLOGICAL SYMPTOM 70
840 PHOTOSENSITIVITY REACTION 70
841 RASH PAPULAR 70
842 URINE ABNORMALITY 70
843 HYPOREFLEXIA 69
844 JAUNDICE 69
845 MENISCUS INJURY 69
846 MOUTH ULCERATION 69
847 PHARYNGITIS STREPTOCOCCAL 69
848 PRODUCT STORAGE ERROR 69
849 SPINAL STENOSIS 69
850 SPLENOMEGALY 69
851 ASCITES 68
852 AUTOIMMUNE DISORDER 68
853 BLOOD IRON DECREASED 68
854 CATATONIA 68
855 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 68
856 PHARYNGITIS 68
857 RESPIRATORY RATE DECREASED 68
858 SCAB 68
859 SPINAL CORD INJURY 68
860 WHITE BLOOD CELLS URINE POSITIVE 68
861 ACUTE RESPIRATORY DISTRESS SYNDROME 67
862 CONJUNCTIVITIS 67
863 DERMATITIS ALLERGIC 67
864 PULMONARY HYPERTENSION 67
865 THERAPY CHANGE 67
866 TIBIA FRACTURE 67
867 URINARY TRACT INFECTION BACTERIAL 67
868 BLOOD COUNT ABNORMAL 66
869 BRADYPHRENIA 66
870 FAECALOMA 66
871 HEPATITIS 66
872 NEEDLE ISSUE 66
873 PYELONEPHRITIS 66
874 BLADDER SPASM 65
875 CONSCIOUSNESS FLUCTUATING 65
876 DECREASED ACTIVITY 65
877 FULL BLOOD COUNT ABNORMAL 65
878 HYPERAMMONAEMIA 65
879 INJECTION SITE INDURATION 65
880 INTENTIONAL SELF-INJURY 65
881 LARYNGITIS 65
882 LUNG NEOPLASM MALIGNANT 65
883 PARAPLEGIA 65
884 PROSTATIC SPECIFIC ANTIGEN INCREASED 65
885 RASH GENERALISED 65
886 GASTROENTERITIS 64
887 HAND DEFORMITY 64
888 HYSTERECTOMY 64
889 INFUSION SITE ERYTHEMA 64
890 INGUINAL HERNIA 64
891 LUMBAR SPINAL STENOSIS 64
892 PHOTOPSIA 64
893 POSTURE ABNORMAL 64
894 PRODUCT PRESCRIBING ISSUE 64
895 TOOTH ABSCESS 64
896 DROOLING 63
897 FAECES DISCOLOURED 63
898 FRUSTRATION TOLERANCE DECREASED 63
899 HAIR TEXTURE ABNORMAL 63
900 HEPATIC FUNCTION ABNORMAL 63
901 IRON DEFICIENCY ANAEMIA 63
902 LUNG INFECTION 63
903 PELVIC PAIN 63
904 PULMONARY THROMBOSIS 63
905 UTERINE LEIOMYOMA 63
906 CLUMSINESS 62
907 COLITIS ULCERATIVE 62
908 CONCOMITANT DISEASE AGGRAVATED 62
909 DRUG SCREEN POSITIVE 62
910 EYE INFECTION 62
911 FUNCTIONAL GASTROINTESTINAL DISORDER 62
912 INCORRECT DRUG ADMINISTRATION DURATION 62
913 PARAESTHESIA ORAL 62
914 PNEUMOTHORAX 62
915 PREMATURE BABY 62
916 WRONG PATIENT RECEIVED PRODUCT 62
917 BLOOD IMMUNOGLOBULIN G DECREASED 61
918 ENTHESOPATHY 61
919 FURUNCLE 61
920 GASTROINTESTINAL PAIN 61
921 GLOSSODYNIA 61
922 HYPOVENTILATION 61
923 INJECTION SITE DISCOLOURATION 61
924 KNEE OPERATION 61
925 LYMPHOCYTE PERCENTAGE DECREASED 61
926 PELVIC FRACTURE 61
927 PETECHIAE 61
928 QUADRIPLEGIA 61
929 TENDON RUPTURE 61
930 THYROID MASS 61
931 VULVOVAGINAL MYCOTIC INFECTION 61
932 DERMATITIS ATOPIC 60
933 FACIAL PARALYSIS 60
934 GLYCOSYLATED HAEMOGLOBIN INCREASED 60
935 GRANULOMA 60
936 IMMOBILE 60
937 IMPLANT SITE ERYTHEMA 60
938 INTENTIONAL DRUG MISUSE 60
939 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 60
940 PANCREATITIS ACUTE 60
941 APPENDICITIS 59
942 DIABETIC NEUROPATHY 59
943 PERSONALITY DISORDER 59
944 POLYURIA 59
945 PRODUCT DISPENSING ERROR 59
946 PURULENT DISCHARGE 59
947 RESPIRATION ABNORMAL 59
948 SOFT TISSUE INJURY 59
949 TRANSAMINASES INCREASED 59
950 BLEPHAROSPASM 58
951 BLOOD ALBUMIN DECREASED 58
952 BLOOD PRESSURE DIASTOLIC DECREASED 58
953 BOWEL MOVEMENT IRREGULARITY 58
954 BRONCHOSPASM 58
955 CEREBRAL ATROPHY 58
956 COELIAC DISEASE 58
957 CYSTITIS NONINFECTIVE 58
958 DEVICE DIFFICULT TO USE 58
959 DIZZINESS POSTURAL 58
960 FINE MOTOR SKILL DYSFUNCTION 58
961 HOSPICE CARE 58
962 HUNGER 58
963 JUVENILE IDIOPATHIC ARTHRITIS 58
964 MULTI-ORGAN FAILURE 58
965 MUSCLE FATIGUE 58
966 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 58
967 PERSONALITY CHANGE 58
968 RENAL TUBULAR NECROSIS 58
969 SUBARACHNOID HAEMORRHAGE 58
970 TROPONIN INCREASED 58
971 URINE OUTPUT DECREASED 58
972 AKATHISIA 57
973 BACTERIAL TEST POSITIVE 57
974 CERVICAL SPINAL STENOSIS 57
975 JOINT NOISE 57
976 LIPOMA 57
977 OESOPHAGITIS 57
978 POST LUMBAR PUNCTURE SYNDROME 57
979 PRODUCT PHYSICAL ISSUE 57
980 SECRETION DISCHARGE 57
981 VAGINAL INFECTION 57
982 DIABETIC KETOACIDOSIS 56
983 EPIDURAL LIPOMATOSIS 56
984 FACE INJURY 56
985 HERPES VIRUS INFECTION 56
986 HOSTILITY 56
987 INCREASED APPETITE 56
988 ISCHAEMIC STROKE 56
989 NEUTROPHIL PERCENTAGE INCREASED 56
990 OVARIAN CYST 56
991 PLATELET COUNT INCREASED 56
992 SPUTUM DISCOLOURED 56
993 DEVICE PHYSICAL PROPERTY ISSUE 55
994 EAR PRURITUS 55
995 GOUT 55
996 HYPERTHYROIDISM 55
997 OBSTRUCTIVE AIRWAYS DISORDER 55
998 ONYCHOMYCOSIS 55
999 UPPER-AIRWAY COUGH SYNDROME 55